Exploring the role of gut microbiota in intervertebral disc degeneration: insights from bidirectional Mendelian randomization analysis
- PMID: 40257470
- DOI: 10.1007/s00586-025-08794-0
Exploring the role of gut microbiota in intervertebral disc degeneration: insights from bidirectional Mendelian randomization analysis
Abstract
Objective: Although previous studies have indicated a potential association between the gut microbiota and intervertebral disc degeneration (IVDD), the precise nature of this relationship remains unclear. The objective of this study is to further explore the potential causal relationship between gut microbiota and IVDD using a bidirectional Mendelian randomization approach, with the aim of identifying potential microbial characteristics associated with IVDD.
Methods: Using the data from genome-wide association studies (GWAS) involving 412 gut microbiota species and 227,388 controls and 29,508 cases of IVDD. Inverse variance weighted (IVW) was used as the primary Mendelian randomization (MR) analysis, complemented by weighted median, MR-Egger regression, weighted mode and simple mode methods. Extensive sensitivity analyses were performed to confirm the robustness of the results and to assess heterogeneity and horizontal pleiotropy.
Results: This study revealed a positive genetic predisposition between 6 types of gut microbiota and IVDD through the IVW method, indicating that increased levels of these microbiota may lead to a higher risk of IVDD. Conversely, 6 types of gut microbiota were found to have negative effects on IVDD, suggesting that increased levels of these microbiota may have a protective effect against IVDD. Reverse MR analysis results revealed such possibilities as 1 positive and 5 negative causal relationships between IVDD and gut microbiota. The results of Cochran's Q test, MR-Egger regression, and MR-PRESSO analysis from the bidirectional Mendelian randomization all yielded p-values greater than 0.05, indicating that there is no significant heterogeneity or pleiotropy in the genetic effect analysis between gut microbiota and IVDD.
Conclusion: We used a bidirectional Mendelian randomization approach to identify various gut microbiota associated with IVDD. Our findings lay the foundation for further exploration of the pathogenesis and treatment strategies of gut microbiota and IVDD, and provide new possibilities for research on biomarkers of IVDD-related metabolic microbiota.
Keywords: Genetic inference; Genome-wide association study; Gut microbiota; Intervertebral disc degeneration; Mendelian randomization.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: All data were publicly available GWAS summary statistics, thus no additional ethical approval or informed consent was required. Conflict of interest: JH X, XL Z, TY X, WQ Z, X X, LM X and YZ Z declare that they have no conflict of interests.
Similar articles
-
Association between sarcopenia and intervertebral disc degeneration: A bidirectional two-sample Mendelian randomization.J Back Musculoskelet Rehabil. 2025 Jul;38(4):902-913. doi: 10.1177/10538127251318926. Epub 2025 Apr 24. J Back Musculoskelet Rehabil. 2025. PMID: 40275698
-
Inflammatory cytokines mediate the gut microbiota-EGPA subtype link: a Mendelian randomization study.Clin Rheumatol. 2025 Jul;44(7):3061-3071. doi: 10.1007/s10067-025-07526-5. Epub 2025 Jun 12. Clin Rheumatol. 2025. PMID: 40500572
-
Causal Relationship Between Cerebrospinal Fluid Metabolites and Intervertebral Disc Disease: A Bidirectional Mendelian Randomization Study.Diagnostics (Basel). 2025 Jun 16;15(12):1526. doi: 10.3390/diagnostics15121526. Diagnostics (Basel). 2025. PMID: 40564845 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
References
-
- Knezevic NN, Candido KD, Vlaeyen JWS, Van Zundert J, Cohen SP (2021) Low back pain. Lancet (London England) 398:78–92 - PubMed
-
- Hoy D et al (2012) A systematic review of the global prevalence of low back pain. Arthritis Rheum 64:2028–2037 - PubMed
-
- Il MI, Sl T, Nh MN, Sa M (2022) Discogenic low back pain: anatomy, pathophysiology and treatments of intervertebral disc degeneration. Int J Mol Sci 24
-
- Cannata F et al (2020) Intervertebral disc degeneration: A focus on obesity and type 2 diabetes. Diabetes Metab Res Rev 36:e3224 - PubMed
MeSH terms
Grants and funding
- U23A6008/the Integration Project of NSFC Joint Fund for Regional Innovation and Development
- 32130052/the Key Projects of the National Natural Science Foundation of China
- 21377731D/the Hygiene and Health Innovation Project of Major project assignment for research and development in Hebei province
- 2021yjsCXCY119/Huazhong University of Science and Technology 19th Batch of Graduate Student Innovation Fund Project
LinkOut - more resources
Full Text Sources